128 related articles for article (PubMed ID: 33044228)
1. Immunoexpression of Apoptosis and Cell-cycle Arrest Markers in Oral Lichen Planus.
Pérez-Sayáns M; Lorenzo-Pouso AI; Chamorro-Petronacci CM; Suárez-Peñaranda JM; Padín-Iruegas E; González-Moles MA; Marichalar-Mendía X; García-García A; Blanco-Carrión A
Appl Immunohistochem Mol Morphol; 2021 May-Jun 01; 29(5):374-381. PubMed ID: 33044228
[TBL] [Abstract][Full Text] [Related]
2. No differences in caspase-3 and Bax expression in atrophic-erosive vs. reticular oral lichen planus.
Bascones-Ilundain C; González-Moles MA; Campo-Trapero J; Gil-Montoya JA; Esparza-Gómez GC; Cano-Sánchez J; Bascones-Martínez A
J Eur Acad Dermatol Venereol; 2008 Feb; 22(2):204-12. PubMed ID: 18211414
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical expression of Bcl-2 and Ki-67 in oral lichen planus and leukoplakia with different degrees of dysplasia.
Pigatti FM; Taveira LA; Soares CT
Int J Dermatol; 2015 Feb; 54(2):150-5. PubMed ID: 25265990
[TBL] [Abstract][Full Text] [Related]
4. Cell cycle regulating mechanisms in oral lichen planus: molecular bases in epithelium predisposed to malignant transformation.
González-Moles MA; Bascones-Ilundain C; Gil Montoya JA; Ruiz-Avila I; Delgado-Rodríguez M; Bascones-Martínez A
Arch Oral Biol; 2006 Dec; 51(12):1093-103. PubMed ID: 16914114
[TBL] [Abstract][Full Text] [Related]
5. Expression of epithelial growth factor receptor as a protein marker in oral reticular and erosive lichen planus.
Keshani F; Kargahi N; Nikbakht MH; Najafi S; Fallah F
BMC Oral Health; 2024 Jun; 24(1):726. PubMed ID: 38914986
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical study on topoisomerase IIalpha, Ki-67 and cytokeratin-19 in oral lichen planus lesions.
Mattila R; Alanen K; Syrjänen S
Arch Dermatol Res; 2007 Jan; 298(8):381-8. PubMed ID: 17072627
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical expression of T-cell subsets (CD4 and CD8) in oral lichen planus.
Rassol HJ; Zaidan TF
Pan Afr Med J; 2023; 45():147. PubMed ID: 37808434
[TBL] [Abstract][Full Text] [Related]
8. Assessment of bax and bcl-2 immunoexpression in patients with oral lichen planus and oral squamous cell carcinoma.
Nafarzadeh S; Jafari S; Bijani A
Int J Mol Cell Med; 2013; 2(3):136-42. PubMed ID: 24551804
[TBL] [Abstract][Full Text] [Related]
9. P53 and bcl-2 immunoexpression in patients with oral lichen planus and oral squamous cell carcinoma.
Leyva-Huerta ER; Ledesma-Montes C; Rojo-Botello RE; Vega-Memije E
Med Oral Patol Oral Cir Bucal; 2012 Sep; 17(5):e745-50. PubMed ID: 22549684
[TBL] [Abstract][Full Text] [Related]
10. [Expressions of proliferating cell nuclear antigen, Bcl-2, and Bax in lymphocytes of patients with oral lichen planus].
Lei L; Tan WX; Yu M; Zhou XL
Nan Fang Yi Ke Da Xue Xue Bao; 2009 May; 29(5):946-8. PubMed ID: 19460716
[TBL] [Abstract][Full Text] [Related]
11. [The expression of apoptosis-associated proteins Bcl-2, Bax in oral leukoplakia and lichen planus].
Fan Y; Zhan Z; Peng T; Song XL; Feng ZQ
Shanghai Kou Qiang Yi Xue; 2004 Dec; 13(6):497-501. PubMed ID: 15619691
[TBL] [Abstract][Full Text] [Related]
12. Higher expressions of p53 and proliferating cell nuclear antigen (PCNA) in atrophic oral lichen planus and patients with areca quid chewing.
Lee JJ; Kuo MY; Cheng SJ; Chiang CP; Jeng JH; Chang HH; Kuo YS; Lan WH; Kok SH
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2005 Apr; 99(4):471-8. PubMed ID: 15772596
[TBL] [Abstract][Full Text] [Related]
13. Apoptosis of oral epithelial cells in oral lichen planus caused by upregulation of BMP-4.
Kim SG; Chae CH; Cho BO; Kim HN; Kim HJ; Kim IS; Choi JY
J Oral Pathol Med; 2006 Jan; 35(1):37-45. PubMed ID: 16393252
[TBL] [Abstract][Full Text] [Related]
14. Increased caspase-3 and altered expression of apoptosis-associated proteins, Bcl-2 and Bax in lichen planus.
Abdel-Latif AM; Abuel-Ela HA; El-Shourbagy SH
Clin Exp Dermatol; 2009 Apr; 34(3):390-5. PubMed ID: 19309373
[TBL] [Abstract][Full Text] [Related]
15. Expression of apoptotic signaling proteins in leukoplakia and oral lichen planus: quantitative and topographical studies.
Tanda N; Mori S; Saito K; Ikawa K; Sakamoto S
J Oral Pathol Med; 2000 Sep; 29(8):385-93. PubMed ID: 10972347
[TBL] [Abstract][Full Text] [Related]
16. Estimation of malignant transformation rate in cases of oral epithelial dysplasia and lichen planus using immunohistochemical expression of Ki-67, p53, BCL-2, and BAX markers.
Shailaja G; Kumar JV; Baghirath PV; Kumar U; Ashalata G; Krishna AB
Dent Res J (Isfahan); 2015; 12(3):235-42. PubMed ID: 26005463
[TBL] [Abstract][Full Text] [Related]
17. Elevated serum levels of the apoptosis related molecules TNF-alpha, Fas/Apo-1 and Bcl-2 in oral lichen planus.
Sklavounou-Andrikopoulou A; Chrysomali E; Iakovou M; Garinis GA; Karameris A
J Oral Pathol Med; 2004 Aug; 33(7):386-90. PubMed ID: 15250829
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical study of syndecan-1 down-regulation and the expression of P35 protein in oral lichen planus: a clinicopathologic correlation with hepatitis C infection in the Egyptian population.
Zyada MM; Fikry HE
Ann Diagn Pathol; 2010 Jun; 14(3):153-61. PubMed ID: 20471559
[TBL] [Abstract][Full Text] [Related]
19. A clinical study of 674 patients with oral lichen planus in China.
Xue JL; Fan MW; Wang SZ; Chen XM; Li Y; Wang L
J Oral Pathol Med; 2005 Sep; 34(8):467-72. PubMed ID: 16091113
[TBL] [Abstract][Full Text] [Related]
20. Implications on pathogenesis and risk of oral lichen planus neoplastic transformation: an ex-vivo retrospective immunohistochemical study.
Squarzanti DF; Cena T; Sorrentino R; Migliario M; Chiocchetti A; Rimondini L; Azzimonti B; Valente G
Histol Histopathol; 2019 Sep; 34(9):1015-1024. PubMed ID: 30907426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
